CWM
ARKG icon

Consultiva Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Consultiva Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.41K Buy
200
+100
+100% +$3.19K 0.02% 231
2026
Q1 		$2.64K Buy
+100
New +$2.93K 0.01% 240

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Consultiva Wealth Management's ARKG Position: Q2 2026 in Review

Consultiva Wealth Management increased its ARK Genomic Revolution ETF (ARKG) stake by 100% in Q2 2026, buying an estimated $3.19K and bringing the position to 200 shares worth $8.41K. The position accounts for 0.02% of the portfolio, ranked #231.

Consultiva Wealth Management first reported a position in ARKG in Q1 2026 and has held it in 2 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Consultiva Wealth Management held 200 shares of ARK Genomic Revolution ETF worth $8.41K as of Q2 2026.
  • Consultiva Wealth Management bought 100 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $3.19K.
  • ARK Genomic Revolution ETF made up 0.02% of Consultiva Wealth Management's portfolio in Q2 2026, its #231 holding.
  • Consultiva Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2026 and has held it in 2 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Consultiva Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.